Christopher Dahl, PA-C | |
1487 Belk Blvd, Oxford, MS 38655-5371 | |
(662) 234-1090 | |
Not Available |
Full Name | Christopher Dahl |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 1487 Belk Blvd, Oxford, Mississippi |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134530181 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Christopher Dahl, PA-C 606 Wildwood Ln, Oxford, MS 38655-2408 Ph: () - | Christopher Dahl, PA-C 1487 Belk Blvd, Oxford, MS 38655-5371 Ph: (662) 234-1090 |
News Archive
Molecular Detection Inc. a company developing Detect-Ready assays designed to increase the speed and accuracy of infectious disease diagnosis, today announced that its Detect-Ready MRSA assay has received its first independent validation in a study conducted at St. George's Healthcare NHS Trust, a leading teaching hospital in the UK.
Starting in 2017, researchers will commence their study in Eindhoven on the effects of days with high air pollution on respiratory complaints, medication use and lung function of children suffering from chronic respiratory complaints such as wheezing or asthma.
A pediatric patient in Marquette, Michigan is being examined by a doctor— but the doctor is 365 miles away in Ann Arbor. Elsewhere in Michigan, a mental health patient, his family and psychiatrist are participating in a commitment hearing in the safe, secure environment of a psychiatric unit— but the judge is actually on the other side of town.
Celera Corporation today announced that it has signed a Declaration of Conformity and applied the CE mark to a real-time PCR (polymerase chain reaction) test for detection of a variant in the KIF6 gene, allowing the test to be marketed in the European Union and other geographic areas that recognize the CE Mark.
Patients with visual impairment due to myopic choroidal neovascularisation achieve better visual acuity after 3 months of individualised treatment with ranibizumab than with verteporfin photodynamic therapy, show the results of a phase III randomised controlled trial.
› Verified 6 days ago
Lillian P Williams, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 111 Eastwind Dr, Oxford, MS 38655 Phone: 615-796-9517 | |
Mrs. Katie Jenkins Mcdaniel, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1626 Highway 30 E, Oxford, MS 38655 Phone: 662-371-1326 Fax: 662-371-1325 | |
Kimberly Carroll Guyton, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1626 Highway 30 E, Oxford, MS 38655 Phone: 662-371-1326 Fax: 662-371-1325 | |
Ms. Romy Abboud, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 705 Sisk Ave # 105, Oxford, MS 38655 Phone: 662-371-1326 Fax: 662-371-1325 | |
Ashley Savannah Roberson, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Baptist Memorial Cir Ste 330, Oxford, MS 38655 Phone: 662-767-4200 Fax: 662-767-4201 | |
Mary Lela Valentine Vonder Haar, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2222 Jackson Ave W, Oxford, MS 38655 Phone: 662-380-5560 |